Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $52.89 USD
Change Today +2.26 / 4.46%
Volume 3.2K
UTMD On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

utah medical products inc (UTMD) Snapshot

Open
$50.55
Previous Close
$50.63
Day High
$52.92
Day Low
$50.55
52 Week High
03/20/15 - $63.98
52 Week Low
10/1/14 - $47.33
Market Cap
198.8M
Average Volume 10 Days
8.4K
EPS TTM
$3.02
Shares Outstanding
3.8M
EX-Date
09/16/15
P/E TM
17.5x
Dividend
$1.02
Dividend Yield
1.92%
Current Stock Chart for UTAH MEDICAL PRODUCTS INC (UTMD)

Related News

No related news articles were found.

utah medical products inc (UTMD) Related Businessweek News

No Related Businessweek News Found

utah medical products inc (UTMD) Details

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company’s labor and delivery/obstetrics, including fetal monitoring accessories, vacuum-assisted delivery systems, and other obstetrical tools; and neonatal intensive care products, such as DISPOSA-HOOD, an infant respiratory hood, as well as DELTRAN PLUS, a blood pressure monitoring system. It also provides umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a pre-assembled and closed urinary drainage system; and MYELO-NATE, a lumbar sampling kit. In addition, the company’s gynecology/urology/electrosurgery products comprising LETZ system to excise cervical intraepithelial neoplasia; EPITOME, an electrosurgical scalpel; FILSHIE CLIP system, a female surgical contraception device; PATHFINDER PLUS, an endoscopic irrigation device; LAWRENCE ADD-A-CATH introducer; and holmium laser fibers. Further, it provides LIBERTY system for the treatment and control of urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other suspected abnormalities of the uterus; LUMIN to manipulate the uterus in laparoscopic procedures; DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components, and other molded parts. The company markets its products to neonatal intensive care unit, labor and delivery department, and women’s health center in hospitals; and outpatient clinics and physician's offices. It sells its products through direct sales and independent manufacturer’s representatives; distributors, national hospital distribution companies, and other medical device manufacturers; and through other medical device companies and independent medical products distributors internationally. The company was founded in 1978 and is headquartered in Midvale, Utah.

172 Employees
Last Reported Date: 03/12/15
Founded in 1978

utah medical products inc (UTMD) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $234.0K
Principal Financial Officer, Chief Administra...
Total Annual Compensation: $111.6K
Compensation as of Fiscal Year 2014.

utah medical products inc (UTMD) Key Developments

Utah Medical Products, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and First Half of 2015; Provides Earnings Guidance for the Year 2015

Utah Medical Products Inc. reported unaudited consolidated earnings results for the second quarter and first half of 2015. For the quarter, the company reported net sales of $10.40 million compared to $10.49 million a year ago. Operating income was $3.97 million compared to $4.06 million a year ago. Income before tax was $3.92 million compared to $3.93 million a year ago. Net income was $2.92 million or $0.773 per share compared to $2.83 million or $0.751 per share a year ago. Excluding the noncash effects of depreciation, amortization of intangible assets and stock option expense, consolidated EBT excluding the re-measured bank balance currency loss and interest expense were $4.793 million compared to $4.946 million in second quarter 2014. The $153,000 lower adjusted consolidated EBITDA resulted primarily from $78,000 lower interest expense, plus $250,000 lower GP offset by $155,000 lower operating expenses and $61,000 lower IIA amortization expense emanating from the significant FX rate changes. For the quarter, the company reported net sales of $20.63 million compared to $20.32 million a year ago. Operating income was $7.84 million compared to $7.91 million a year ago. Income before tax was $7.59 million compared to $7.71 million a year ago. Net income was $5.59 million or $1.480 per share compared to $5.56 million or $1.470 per share a year ago. Year-to-date ROE was 17% (prior to dividends), 11% (after accrual of shareholder dividends). Adjusted consolidated EBITDA were $9.491 million compared to $9.659 million in first half 2014. The $168 lower EBITDA resulted from $100,000 lower interest expense plus the combination of the following differences emanating primarily from FX rate changes: $188,000 lower GP offset by $127,000 lower operating expenses, $117,000 lower USD-denominated IIA amortization expense, and $158,000 higher loss from re-measured foreign currency bank balances. The company is remain optimistic about meeting its projection for 2015 net profits and EPS described in its 2014.

Utah Medical Products Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Utah Medical Products Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of $10,233,000 against $9,827,000 a year ago. Operating income was $3,877,000 compared to $3,843,000 a year ago. Income before tax was $3,668,000 compared to $3,782,000 a year ago. Net income was $2,667,000 or $0.706 per share against $2,722,000 or $0.719 per share a year ago. The $114 lower EBT can be attributed to a $177 loss on the remeasured value of Euro cash balances in the UK, which dropped by more than 11% in value relative to the U.S. Dollar at the end of first quarter of 2015 from the end of fourth quarter of 2014. The company noted its consolidated sales were reduced by foreign exchange, as it invoices approximately one-third of its sales in foreign currencies. The sales growth would have been about 8% in constant currencies.

Utah Medical Products Inc., Annual General Meeting, May 01, 2015

Utah Medical Products Inc., Annual General Meeting, May 01, 2015., at 12:00 US Mountain Standard Time. Location: 7043 South 300 West. Agenda: To elect two directors to serve terms expiring at the 2018 annual meeting and until successors are elected and qualified; to ratify the selection of Jones Simkins LLC as the company’s independent public accounting firm for the year ending December 31, 2015; and to hold an advisory vote on the company’s executive compensation program.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTMD:US $52.89 USD +2.26

UTMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bovie Medical Corp $2.30 USD -0.06
IRIDEX Corp $6.89 USD +0.17
MGC Diagnostics Corp $5.25 USD +0.22
Misonix Inc $11.37 USD +0.39
Synergetics USA Inc $4.35 USD -0.04
View Industry Companies
 

Industry Analysis

UTMD

Industry Average

Valuation UTMD Industry Range
Price/Earnings 17.5x
Price/Sales 4.8x
Price/Book 2.9x
Price/Cash Flow 17.4x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UTAH MEDICAL PRODUCTS INC, please visit www.utahmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.